Sana Klinikum Lichtenberg, Berlin Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT01172223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Frauenklinik, Sana Klinikum Lichtenberg, Fanningerstr. 32, D-10365 Berlin, Germany | Prof Dirk Elling | Sana-Klinikum Lichtenberg

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4